Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new...
The highly anticipated #empowHERaccess Global Prestige Awards 2025 returns for its fifth year, honoring global leaders who are shaping the AI-powered economy while driving corporate ESG...
A new daily pill for endometriosis has been approved for use on the NHS and could help over a thousand women in England every year manage...
Femtech Canada, operated by Innovation Factory, has entered into a strategic partnership with Sun Life to support the development of commercialisation programming designed to drive the...
Reflecting on how fitness posts on social media make them feel may help young women reduce the harmful tendency to compare themselves to idealised influencers and...
Recently published research has turned an overdue spotlight on the disproportionate burden of dementia borne by women. It is encouraging to see this research progressing, and...
New research is debunking the internet belief that if women time their resistance training to specific phases of their menstrual cycle, it boosts the body’s ability...
A new report has uncovered significant biological differences between men and women in their response to popular weight loss medications like Ozempic and Zepbound, according to...
For the first time, a long-term, daily pill for the treatment of endometriosis will now be available on the NHS. The combination treatment pill, relugolix–estradiol–norethisterone, is...
Two new studies have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating autoimmune disease that causes fibrosis (tissue...
